Clinical Trials Directory

Trials / Unknown

UnknownNCT03982329

Impact of nrTMS Therapy on the Progress of Neurorehabilitation

Evaluation of the Benefit of Navigated Repetitive Transcranial Magnetic Stimulation for Therapy of Surgery-related Motor Deficits in Brain Tumor Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
39 (estimated)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Low-frequency navigated repetitive transcranial magnetic stimulation (nrTMS) of the non-damaged hemisphere to increase cortical excitability of the damaged hemisphere and to reduce the increased neuronal inhibition in patients suffering from new surgery-related paresis after brain tumor resection

Detailed description

Postoperative loss of motor function greatly impairs the patients' quality of life and life expectancy of patients with brain tumors is significant limited. Hence the reduction of time spent on neurorehabilitation is very important. Inclusion of patients that underwent brain tumor resection with a surgery-related paresis of the upper extremity. Randomized controlled and double blinded trial - 2/3 nrTMS, 1/3 sham. Fifteen minutes low-frequency nrTMS (1 Hz) of the uneffected hemisphere at 7 consecutive days: nrTMS group or sham group. Thirty minutes physical therapy of the upper extremity in both groups. MRI, nTMS motor mapping, assessments for motor status of upper extremity including Fugl-Meyer-Assessment (FMA), National Institution of Health Stroke Scale (NIHSS), Jebsen Taylor Hand Function Test (JTHFT), Nine Hole Peg Test (NHPT), and Karnofsky Performance Scale (KPS) postoperatively, after the 7th day of intervention and after 3 months.

Conditions

Interventions

TypeNameDescription
DEVICEnavigated repetitive transcranial magnetic stimulation
PROCEDUREphysical therapy

Timeline

Start date
2015-06-01
Primary completion
2019-06-01
Completion
2019-07-01
First posted
2019-06-11
Last updated
2019-06-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03982329. Inclusion in this directory is not an endorsement.